| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |